HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £3.11bn
- £4.17bn
- $3.35bn
Hikma Pharmaceutical - Holding(s) in Company
Hikma Pharmaceutical - Holding(s) in Company
UK Stocks-Factors to watch on June 5 (updated)
UK Stocks-Factors to watch on June 5
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case
Brief: Hikma Launches Tofacitinib Oral Solution In The U.S.
Hikma Pharmaceutical - Director/PDMR Shareholding
Brief: Hikma Pharmaceuticals Announces Major Expansion In Ohio, Creating 350 New Jobs And Investing $267 Million
Hikma Pharmaceutical - Director/PDMR Shareholding
Europe Research Roundup: Burberry, Hochtief, Volex
US appeals court revives Amarin heart-drug patent lawsuit over Hikma generic - June 25, 2024
US Supreme Court hears patent case with potentially sweeping implications for generics
BridgeBio slips as Pfizer patent deal disappoints investors
Pfizer secures deals to keep heart drug free of generic rivals until 2031 (updated)
Brief: Pfizer reaches settlement agreements with Dexcel Pharma, Hikma & Cipla for Vyndamax
Hikma Pharmaceutical - Director/PDMR Shareholding
Brief: Hikma Says All AGM Resolutions Passed By Shareholders
UK Stocks-Factors to watch on April 23 (updated)